Does wealth make health? Cherchez la renal replacement therapy

Clinical Kidney Journal

Volumn 10, Issue 1, 2017, Pages 45-48

  Sanchez Nino, Maria D ^a,b   Ortiz, Alberto ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Section of Nephrology   (Spain)

Author keywords

Chronic kidney disease; Disadvantaged; Glomerulonephritis; Mortality; Poverty; Renal replacement therapy; Translational research; Transplantation

Indexed keywords

ARTERIOVENOUS FISTULA; CHRONIC KIDNEY FAILURE; END STAGE RENAL DISEASE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SOCIAL STATUS; TRANSLATIONAL RESEARCH;

EID: 85015915391     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfw149     Document Type: Review

References (25)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150
2. Ortiz A. Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology. Clin Kidney J 2015; 8: 14-22
3. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-171
4. Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One 2013; 8: e72860
5. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016; 388: 1813-1850
6. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276
7. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and National life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459-1544
8. Beeston CMG, Ford J, Wimbush E et al. Health inequalities policy review for the scottish ministerial task force on health inequalities. Edinburgh, UK: NHS Health Scotland, 2014
9. Garcia-Garcia G, Jha V, Tao Li PK et al. Chronic kidney disease (CKD) in disadvantaged populations. Clin Kidney J 2015; 8: 3-6
10. Abraham G, Varughese S, Thandavan T et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J 2016; 9: 135-141
11. Martin-Cleary C, Ortiz A. CKD hotspots around the world: where, why and what the lessons are. A CKJ review series. Clin Kidney J 2014; 7: 519-523
12. McQuarrie EP, Mackinnon B, Bell S et al. Multiple socioeconomic deprivation and impact on survival in patients with primary glomerulonephritis. Clin Kidney J 2017; 10: 49-54
13. Wilmink T, Wijewardane A, Lee K et al. Effect of ethnicity and socioeconomic status on vascular access provision and performance in an urban NHS hospital. Clin Kidney J 2017; 10: 62-67
14. Nee R, Yuan CM, Hurst FP et al. Impact of poverty and race on pre-end-stage renal disease care among dialysis patients in the United States. Clin Kidney J 2017; 10: 55-61
15. McQuarrie EP, Mackinnon B, McNeice V et al. The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation. Kidney Int 2014; 85: 198-203
16. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants fromliving donors. N Engl J Med 2001; 344: 726-731
17. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277
18. Goodkin DA, Young EW, Kurokawa K et al. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004; 44: 16-21
19. Zhang H, Schaubel DE, Kalbfleisch JD et al. Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int 2012; 81: 1108-1115
20. Tentori F, Zhang J, Li Y et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2012; 27: 4180-4188
21. Ortiz A, Covic A, Fliser D et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 2014; 383: 1831-1843
22. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7: 198-207
23. Bradbury BD, Fissell RB, Albert JM et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007; 2: 89-99
24. Marrón B, Craver L, Remón C et al. 'Reality anddesire' in the care of advanced chronic kidney disease. NDT Plus 2010; 3: 431-435
25. Marrón B, Ortiz A, de Sequera P et al. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy-A Spanish multicentre experience. Nephrol Dial Transplant 2006; 21 (Suppl 2): ii51-ii55